HCMT
NBRV

Highland Capital Management (Texas)’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Highland Capital Management (Texas)’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,162
Closed -$2.76M – 303
2015
Q3 		$2.76M Buy
+1,162
New +$3.08M 0.08% 171

Other funds holding NBRV

WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Highland Capital Management (Texas)'s NBRV Position: Q4 2015 in Review

Highland Capital Management (Texas) sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2015, closing a stake of 1,162 shares — an estimated $2.76M sold.

Highland Capital Management (Texas) first reported a position in NBRV in Q3 2015 and held it in 1 quarter. The position peaked at $2.76M in Q3 2015. 21 funds tracked by Wall St. Rank hold NBRV as of Q4 2015.

  • Highland Capital Management (Texas) reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 1,162 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2015, an estimated $2.76M.
  • Highland Capital Management (Texas) first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $2.76M in Q3 2015.
  • 21 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2015, filed 16 Feb 2016.